Article
Gainesville, Fla. - One medication approved for gum disease appears to be effective against moderate facial acne at sub-antimicrobial doses given over six months.
Novel RF and HIFES Device is Effective for Enhancing Facial Laxity Among Asian Patients
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Patricia Farris, MD, on AP31’s Anti-Aging Power
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
First Patient Dosed in Phase 1 Study of Attovia's ATTO-1310 for Chronic Pruritus
Exploring Oral Therapies for Hyperhidrosis: Current and Future Perspectives